U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03426722) titled 'L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors' on Jan. 29, 2018.
Brief Summary: we aim to evaluate the efficacy of L-carnitine for the treatment of muscle cramps after imatinib in patients with GIST and apply in the future.
Study Type: Interventional
Condition: Gastrointestinal Stromal Tumors (GISTs)
Intervention: * Drug: L-carnitine
L-carnitine VS Placebo is randomized (1:1)
L-carnitine 500mg TID(PO),
First evaluation will be performed at 8 weeks and then unblinding will be done. If symptoms continue after treatment, dose escalation in L-carnitine group by 1000mg T...